GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Accounts Payable & Accrued Expense

Valeo Pharma (TSX:VPH) Accounts Payable & Accrued Expense : C$15.79 Mil (As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Accounts Payable & Accrued Expense?

Valeo Pharma's quarterly accounts payable & accrued expense declined from Jul. 2023 (C$14.37 Mil) to Oct. 2023 (C$11.42 Mil) but then increased from Oct. 2023 (C$11.42 Mil) to Jan. 2024 (C$15.79 Mil).

Valeo Pharma's annual accounts payable & accrued expense increased from Oct. 2021 (C$10.22 Mil) to Oct. 2022 (C$12.46 Mil) but then declined from Oct. 2022 (C$12.46 Mil) to Oct. 2023 (C$11.42 Mil).


Valeo Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for Valeo Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Accounts Payable & Accrued Expense Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial 4.38 4.11 10.22 12.46 11.42

Valeo Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.12 13.13 14.37 11.42 15.79

Valeo Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Valeo Pharma (TSX:VPH) Business Description

Industry
Traded in Other Exchanges
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
Executives
Luc Mainville Senior Officer

Valeo Pharma (TSX:VPH) Headlines

No Headlines